Log in
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.

NASDAQ:PPDI - Pharmaceutical Product Development Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Pharmaceutical Product Development, Inc is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services. Read More…

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:PPDI



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive PPDI News and Ratings via Email

Sign-up to receive the latest news and ratings for PPDI and its competitors with MarketBeat's FREE daily newsletter.


A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

Pharmaceutical Product Development (NASDAQ:PPDI) Frequently Asked Questions

What is Pharmaceutical Product Development's stock symbol?

Pharmaceutical Product Development trades on the NASDAQ under the ticker symbol "PPDI."

Has Pharmaceutical Product Development been receiving favorable news coverage?

News articles about PPDI stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pharmaceutical Product Development earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the healthcare company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Pharmaceutical Product Development.

What other stocks do shareholders of Pharmaceutical Product Development own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmaceutical Product Development investors own include BHP Group (BHP), Bank of America (BAC), Texas Instruments (TXN), Starz Acquisition (STRZA), NVIDIA (NVDA), Northern Trust (NTRS), Intel (INTC), Gulfport Energy (GPOR), Finisar (FNSR) and Advanced Micro Devices (AMD).

How do I buy shares of Pharmaceutical Product Development?

Shares of PPDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pharmaceutical Product Development's official website?

The official website for Pharmaceutical Product Development is http://www.ppdi.com/.

How can I contact Pharmaceutical Product Development?

Pharmaceutical Product Development's mailing address is 929 N Front St, WILMINGTON, NC 28401-3331, United States. The healthcare company can be reached via phone at +1-910-2510081.

MarketBeat Community Rating for Pharmaceutical Product Development (NASDAQ PPDI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  98 (Vote Underperform)
Total Votes:  198
MarketBeat's community ratings are surveys of what our community members think about Pharmaceutical Product Development and other stocks. Vote "Outperform" if you believe PPDI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPDI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Buy Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel